Literature DB >> 8726660

CCAAT/enhancer binding protein is involved in the expression of the tumour necrosis factor gene in human monocytes.

A Wedel1, G Sulski, H W Ziegler-Heitbrock.   

Abstract

Within the human TNF promoter we have identified two sites at positions -189 and -101 that show C/EBP specific binding of nuclear proteins from cells of the human monocytic line Mono Mac 6. Supershift analysis with anti C/EBP antibodies revealed that the complexes formed consist of both C/EBP alpha and C/EBP beta. When studying reporter constructs with a 5'-deletion series of the TNF promoter in cotransfection experiments with a C/EBP beta expression plasmid, a construct with the -1064 TNF fragment gave 26-fold transactivation, the -630 fragment showed 23-fold transactivation and the -107 fragment (containing the -101 C/EBP binding motif) still gave 16-fold transactivation. Mutagenesis of the -101 site in the -630 construct resulted in a reduction of C/EBP driven transactivation from 26-fold to 7-fold. Finally, when Mono Mac 6 cells were transfected with these constructs, stimulation by LPS induced a 19-fold transactivation in the -630 wild type construct, while the -630 construct carrying the -101 mutation was transactivated only 4-fold. Hence, the data indicate that the -101 C/EBP motif is crucial for TNF gene expression in human monocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8726660     DOI: 10.1006/cyto.1996.0046

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  11 in total

Review 1.  Transcriptional control of the TNF gene.

Authors:  James V Falvo; Alla V Tsytsykova; Anne E Goldfeld
Journal:  Curr Dir Autoimmun       Date:  2010-02-18

Review 2.  Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system.

Authors:  Sara L Montgomery; William J Bowers
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-05       Impact factor: 4.147

3.  Tumor necrosis factor alpha gene regulation: enhancement of C/EBPbeta-induced activation by c-Jun.

Authors:  A Zagariya; S Mungre; R Lovis; M Birrer; S Ness; B Thimmapaya; R Pope
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

4.  NF-kappaB1 (p50) is upregulated in lipopolysaccharide tolerance and can block tumor necrosis factor gene expression.

Authors:  S Kastenbauer; H W Ziegler-Heitbrock
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

Review 5.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

6.  Differential role for c-Rel and C/EBPbeta/delta in TLR-mediated induction of proinflammatory cytokines.

Authors:  Yong-Chen Lu; Ira Kim; Elizabeth Lye; Fang Shen; Nobutaka Suzuki; Shinobu Suzuki; Steve Gerondakis; Shizuo Akira; Sarah L Gaffen; Wen-Chen Yeh; Pamela S Ohashi
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

7.  Induction of tumor necrosis factor-alpha (TNF-alpha) by interleukin-12 p40 monomer and homodimer in microglia and macrophages.

Authors:  Malabendu Jana; Subhajit Dasgupta; Ramendra N Saha; Xiaojuan Liu; Kalipada Pahan
Journal:  J Neurochem       Date:  2003-07       Impact factor: 5.372

8.  Silencing of Abcd1 and Abcd2 genes sensitizes astrocytes for inflammation: implication for X-adrenoleukodystrophy.

Authors:  Jaspreet Singh; Mushfiquddin Khan; Inderjit Singh
Journal:  J Lipid Res       Date:  2008-08-21       Impact factor: 5.922

9.  CCAAT-enhancer binding protein-β expression and elevation in Alzheimer's disease and microglial cell cultures.

Authors:  Ron Strohmeyer; Jadd Shelton; Christopher Lougheed; Trisia Breitkopf
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

10.  Mapping Variation in Cellular and Transcriptional Response to 1,25-Dihydroxyvitamin D3 in Peripheral Blood Mononuclear Cells.

Authors:  Silvia N Kariuki; Joseph C Maranville; Shaneen S Baxter; Choongwon Jeong; Shigeki Nakagome; Cara L Hrusch; David B Witonsky; Anne I Sperling; Anna Di Rienzo
Journal:  PLoS One       Date:  2016-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.